NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.
paper
Cited
Public
Unavailable
- Authors
- Krystal, John H; Petrakis, Ismene L; Krupitsky, Evgeny; Schutz, Christian; Trevisan, Louis; D'Souza, D Cyril
- Year
- 2003
- Journal
- Annals of the New York Academy of Sciences
- PMID
- 14684445
- DOI
- 10.1196/annals.1300.010
This paper reviews clinical evidence suggesting that antagonism of the N-methyl-D-aspartate subtype of glutamate receptors by ethanol may convey an important component of the ethanol intoxication signal, that is, subjective and objective responses associated with the consumption of a large amount of ethanol. It will then review recent evidence that two phenotypes associated with increased risk for heavy alcohol consumption, recovering ethanol-dependent patients, and healthy individuals with a family history of alcohol dependence, exhibit reduced sensitivity to the dysphoric consequences of administration of the NMDA receptor antagonist, ketamine. Each of these groups displays reduced sensitivity to a potentially important response that might normally trigger the cessation of ethanol consumption. These data raise the possibility that alterations in NMDA receptor function that reduce the response to the NMDA antagonist component of ethanol may increase the risk for heavy drinking. This hypothesis is consistent with growing evidence that NMDA receptor antagonists may play a role in the treatment of alcoholism by suppressing alcohol withdrawal, reducing the development or expression of alcohol tolerance, or preventing or reversing the sensitiziation to ethanol effects.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems. | Sharma P et al. | โ | 2025 | โ |
| Clinical applications of small-molecule GABA<sub>A</sub>R modulators for neurological disorders. | Chen G et al. | โ | 2024 | โ |
| Modulation of neuronal excitability by binge alcohol drinking. | Gimenez-Gomez P et al. | โ | 2023 | โ |
| Schedule-induced alcohol intake during adolescence sex dependently impairs hippocampal synaptic plasticity and spatial memory. | Sanz-Martos AB et al. | โ | 2023 | โ |
| The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review. | Goldfine CE et al. | โ | 2023 | โ |
| Effects of ethanol on GluN1/GluN2A and GluN1/GluN2B NMDA receptor-ion channel gating kinetics. | Peoples RW et al. | โ | 2022 | โ |
| Prevention of glutamate excitotoxicity in lateral habenula alleviates ethanol withdrawal-induced somatic and behavioral effects in ethanol dependent mice. | Gakare SG et al. | โ | 2022 | โ |
| Rewarding effect of ethanol-induced conditioned place preference in mice: Effect of the monoterpenoid linalool. | Yunusoฤlu O | โ | 2022 | โ |
| Adolescent Ingestions: Various Reasons and Medications. | Sheridan DC et al. | โ | 2021 | โ |
| Effect of ketamine on binge drinking patterns in crossed high alcohol-preferring (cHAP) mice. | Ardinger CE et al. | โ | 2021 | โ |
| Negative allosteric modulation of metabotropic glutamate receptor 5 attenuates alcohol self-administration in baboons. | Salling MC et al. | โ | 2021 | โ |
| Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019. | Corkery JM et al. | โ | 2021 | โ |
| TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. | Ho MF et al. | โ | 2021 | โ |
| [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence]. | Krupitsky EM et al. | โ | 2020 | โ |
| Concomitant taurine exposure counteracts ethanol-induced changes in locomotor and anxiety-like responses in zebrafish. | Fontana BD et al. | โ | 2020 | โ |
| Family history of substance use disorders: Significance for mental health in young adults who gamble. | Grant JE et al. | โ | 2020 | โ |
| Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial. | Krishnan-Sarin S et al. | โ | 2020 | โ |
| Randomized trial to assess safety/feasibility of memantine administration during residential treatment for alcohol use disorder: a pilot study. | Lewis B et al. | โ | 2020 | โ |
| Acute alcohol effects on conditioned pain modulation, but not temporal summation of pain. | Horn-Hofmann C et al. | โ | 2019 | โ |
| Ethanol-induced changes in synaptic amino acid neurotransmitter levels in the nucleus accumbens of differentially sensitized mice. | Nashed MG et al. | โ | 2019 | โ |
| Excitatory/inhibitory balance across ontogeny contributes to age-specific behavioral outcomes of ethanol-like challenge in conditioned taste aversion. | Dannenhoffer CA et al. | โ | 2019 | โ |
| Increased Alcohol-Drinking Induced by Manipulations of mGlu5 Phosphorylation within the Bed Nucleus of the Stria Terminalis. | Campbell RR et al. | โ | 2019 | โ |
| A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity. | Schuckit MA | โ | 2018 | โ |
| Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation. | Shah P et al. | โ | 2018 | โ |
| Alcohol and pharmacologically similar sedatives impair encoding and facilitate consolidation of both recollection and familiarity in episodic memory. | Doss MK et al. | โ | 2018 | โ |
| Effects of AMPA receptor antagonist, NBQX, and extrasynaptic GABA<sub>A</sub> agonist, THIP, on social behavior of adolescent and adult rats. | Dannenhoffer CA et al. | โ | 2018 | โ |
| GABA and Glutamate Synaptic Coadaptations to Chronic Ethanol in the Striatum. | Cuzon Carlson VC | โ | 2018 | โ |
| Phencyclidine-Based New Psychoactive Substances. | Wallach J et al. | โ | 2018 | โ |
| Taurine modulates acute ethanol-induced social behavioral deficits and fear responses in adult zebrafish. | Fontana BD et al. | โ | 2018 | โ |
| Alcohol Triggers Reemergence of Ketamine-Like Experience in a Ketamine Ex-User. | Chang F et al. | โ | 2017 | โ |
| NMDA Glutamate Receptor Antagonism and the Heritable Risk for Alcoholism: New Insights from a Study of Nitrous Oxide. | Krystal JH et al. | โ | 2017 | โ |
| The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers. | Walsh K et al. | โ | 2017 | โ |
| The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies. | de la Peรฑa JB et al. | โ | 2016 | โ |
| Alcohol use in bipolar disorder: A neurobiological model to help predict susceptibility, select treatments and attenuate cortical insult. | Chitty KM et al. | โ | 2015 | โ |
| Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs. | Karoly HC et al. | โ | 2015 | โ |
| Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. | Wong A et al. | โ | 2015 | โ |
| Psychiatric morbidity in ketamine users attending counselling and youth outreach services. | Tang WK et al. | โ | 2015 | โ |
| Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans. | Xu K et al. | โ | 2015 | โ |
| The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study. | Chitty KM et al. | โ | 2015 | โ |
| Brain-derived neurotrophic factor mediates the suppression of alcohol self-administration by memantine. | Jeanblanc J et al. | โ | 2014 | โ |
| Deep resequencing of 17 glutamate system genes identifies rare variants in DISC1 and GRIN2B affecting risk of opioid dependence. | Xie P et al. | โ | 2014 | โ |
| Ketamine: repurposing and redefining a multifaceted drug. | Potter DE et al. | โ | 2014 | โ |
| Alterations in ethanol-induced behaviors and consumption in knock-in mice expressing ethanol-resistant NMDA receptors. | den Hartog CR et al. | โ | 2013 | โ |
| Diurnal pituitary-adrenal activity during schedule-induced polydipsia of water and ethanol in cynomolgus monkeys (Macaca fascicularis). | Helms CM et al. | โ | 2013 | โ |
| Effects of memantine on event-related potential, oscillations, and complexity in individuals with and without family histories of alcoholism. | Narayanan B et al. | โ | 2013 | โ |
| From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine. | Corazza O et al. | โ | 2013 | โ |
| Involvement of sphingolipids in ethanol neurotoxicity in the developing brain. | Saito M et al. | โ | 2013 | โ |
| Pre-exposure to ethanol, but not to caffeine and nicotine, induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletilยฎ. | de la Peรฑa JB et al. | โ | 2013 | โ |
| Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. | Krystal JH et al. | โ | 2013 | โ |
| Alcohol withdrawal syndrome. | Carlson RW et al. | โ | 2012 | โ |
| A role for pharmacotherapy in the treatment of "internet addiction". | Camardese G et al. | โ | 2012 | โ |
| Effects of D-cycloserine on craving to alcohol cues in problem drinkers: preliminary findings. | Hofmann SG et al. | โ | 2012 | โ |
| Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression. | Luckenbaugh DA et al. | โ | 2012 | โ |
| Heterozygous deletion of NR1 subunit of the NMDA receptor alters ethanol-related behaviors and regional expression of NR2 subunits in the brain. | Du X et al. | โ | 2012 | โ |
| Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism. | Jamadar S et al. | โ | 2012 | โ |
| Novel glutamatergic agents for major depressive disorder and bipolar disorder. | Machado-Vieira R et al. | โ | 2012 | โ |
| Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. | Krystal JH et al. | โ | 2011 | โ |
| Effect of the selective NMDA NR2B antagonist, ifenprodil, on acute tolerance to ethanol-induced motor impairment in adolescent and adult rats. | Ramirez RL et al. | โ | 2011 | โ |
| Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence. | Roche DJ et al. | โ | 2010 | โ |
| Decreases in recollective experience following acute alcohol: a dose-response study. | Bisby JA et al. | โ | 2010 | โ |
| Ethanol-like effects of thiopental and ketamine in healthy humans. | Dickerson D et al. | โ | 2010 | โ |
| Glutamatergic modulators: the future of treating mood disorders? | Zarate C et al. | โ | 2010 | โ |
| Hangover and risk for alcohol use disorders: existing evidence and potential mechanisms. | Piasecki TM et al. | โ | 2010 | โ |
| Human variation in alcohol response is influenced by variation in neuronal signaling genes. | Joslyn G et al. | โ | 2010 | โ |
| Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. | Grant JE et al. | โ | 2010 | โ |
| Neuropharmacology of addiction and how it informs treatment. | Lingford-Hughes A et al. | โ | 2010 | โ |
| Aniracetam and DNQX affect the acquisition of rapid tolerance to ethanol in mice. | Rial D et al. | โ | 2009 | โ |
| Contribution of early environmental stress to alcoholism vulnerability. | Campbell JC et al. | โ | 2009 | โ |
| Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. | Phelps LE et al. | โ | 2009 | โ |
| Ketamine and the next generation of antidepressants with a rapid onset of action. | Machado-Vieira R et al. | โ | 2009 | โ |
| Pharmacotherapy of addictive disorders. | Ross S et al. | โ | 2009 | โ |
| The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. | Machado-Vieira R et al. | โ | 2009 | โ |
| Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors. | Trevisan L et al. | โ | 2008 | โ |
| Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. | Szumlinski KK et al. | โ | 2008 | โ |
| A systematic review of off-label uses of memantine for psychiatric disorders. | Zdanys K et al. | โ | 2008 | โ |
| Choroid plexus dysfunction: the initial event in the pathogenesis of Wernicke's encephalopathy and ethanol intoxication. | Nixon PF et al. | โ | 2008 | โ |
| Determination of amino acid levels in the rat striatum, after administration of ethanol alone and associated with ketamine, a glutamatergic antagonist. | Vasconcelos SM et al. | โ | 2008 | โ |
| Homers regulate drug-induced neuroplasticity: implications for addiction. | Szumlinski KK et al. | โ | 2008 | โ |
| Neuroactive steroid stereospecificity of ethanol-like discriminative stimulus effects in monkeys. | Grant KA et al. | โ | 2008 | โ |
| Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain". | Sullivan EV et al. | โ | 2008 | โ |
| Practitioner review: adolescent alcohol use disorders: assessment and treatment issues. | Perepletchikova F et al. | โ | 2008 | โ |
| Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies. | Klugmann M et al. | โ | 2008 | โ |
| Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. | Johnson BA | โ | 2008 | โ |
| Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats. | Sharma AN et al. | โ | 2007 | โ |
| Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. | Wrase J et al. | โ | 2007 | โ |
| Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. | Krupitsky EM et al. | โ | 2007 | โ |
| Psychiatric safety of ketamine in psychopharmacology research. | Perry EB et al. | โ | 2007 | โ |
| Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. | Mason GF et al. | โ | 2006 | โ |
| Ethanol-induced hypnotic tolerance is absent in N-methyl-D-aspartate receptor epsilon 1 subunit knockout mice. | Sato Y et al. | โ | 2006 | โ |
| Psychological effects of ketamine in healthy volunteers. Phenomenological study. | Pomarol-Clotet E et al. | โ | 2006 | โ |
| The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. | Krystal JH et al. | โ | 2006 | โ |
| Effect of natural and synthetic polyamines on ethanol intake in UChB drinker rats. | Bilbeny N et al. | โ | 2005 | โ |
| Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras. | Suvarna N et al. | โ | 2005 | โ |
| Management of delirium tremens. | DeBellis R et al. | โ | 2005 | โ |
| Acute effects of memantine in combination with alcohol in moderate drinkers. | Bisaga A et al. | โ | 2004 | โ |
| Assessing the efficacy of medical treatments for alcohol use disorders. | Moak DH | โ | 2004 | โ |
| Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment. | Self RL et al. | โ | 2004 | โ |